Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Cyprumed said MSD has initiated a Phase I clinical trial of a proprietary drug candidate using its oral tablet technology. The start triggers a milestone payment under their collaboration agreement.
CYPRUMED GmbH/ Key word(s): StudyCyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial29.09.2026 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initia…